Remedica Limited

Ukraine

All drugs from this manufacturer

  • ABIRATERONE-VISTA

    The drug is prescribed for adult men for the treatment of metastatic prostate cancer (both newly diagnosed high-risk and castration-resistant prostate cancer).

    Dosage form: tablets, film-coated

    Active substance Dosage
    abiraterone acetate 250 mg

    ATC: L02BX03

  • ABIRATERONE-VISTA

    The drug is prescribed to adult men for the treatment of metastatic prostate cancer at various stages (both hormone-sensitive and castration-resistant), particularly after unsuccessful chemotherapy.

    Dosage form: tablets, film-coated

    Active substance Dosage
    abiraterone 500 mg

    ATC: L02BX03

  • CAPCITABINE-VISTA

    The drug is used for the treatment of colon cancer (colorectal cancer) and stomach cancer. It is also used for the treatment of breast cancer.

    Dosage form: tablets, film-coated

    Active substance Dosage
    capecitabine 150 mg

    ATC: L01BC06

  • CAPCITABINE-VISTA

    The drug is used to treat colon cancer (colorectal cancer) and stomach cancer. It is also used to treat breast cancer.

    Dosage form: tablets, film-coated

    Active substance Dosage
    capecitabine 500 mg

    ATC: L01BC06

  • CAPEVISTA

    The drug is used for the treatment of colon cancer (colorectal cancer), stomach cancer, and breast cancer.

    Dosage form: tablets, film-coated

    Active substance Dosage
    capecitabine 150 mg

    ATC: L01BC06

  • CAPEVISTA

    The drug is used for the treatment of colon cancer (colorectal cancer), stomach cancer, as well as breast cancer.

    Dosage form: tablets, film-coated

    Active substance Dosage
    capecitabine 500 mg

    ATC: L01BC06

  • ERLOTINIB-VISTA

    The drug is prescribed for the treatment of non-small cell lung cancer (as first-line therapy in the presence of certain mutations, for maintenance therapy, or after ineffective chemotherapy), as well as for the treatment of metastatic pancreatic cancer in combination with gemcitabine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 25 mg

    ATC: L01EB02

  • ERLOTINIB-VISTA

    The drug is prescribed for the treatment of non-small cell lung cancer (as first-line therapy in the presence of certain mutations, as maintenance therapy, or after ineffective chemotherapy), as well as for the treatment of metastatic pancreatic cancer in combination with gemcitabine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 50 mg

    ATC: L01EB02

  • ERLOTINIB-VISTA

    The drug is used for the treatment of non-small cell lung cancer (as first-line therapy or for maintenance after chemotherapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 100 mg

    ATC: L01EB02

  • ERLOTINIB-VISTA

    The drug is prescribed for the treatment of non-small cell lung cancer (as first-line therapy, as maintenance therapy, or after ineffective chemotherapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 150 mg

    ATC: L01EB02

  • EXEMESTANE-VISTA AC

    The drug is indicated for women in the postmenopausal period for adjuvant therapy of early-stage breast cancer (after 2–3 years of tamoxifen therapy), as well as for the treatment of advanced breast cancer if the disease progresses after the use of antiestrogens.

    Dosage form: tablets, film-coated

    Active substance Dosage
    exemestane 25 mg

    ATC: L02BG06